Literature DB >> 21586980

Treatment of recurrent mandibular ameloblastoma with segmental resection and revascularized fibula free flap.

Roberto Becelli1, Roberto Morello, Giancarlo Renzi, Giorgio Matarazzo, Chiara Dominici.   

Abstract

The adamantinoma is characterized by a high rate of local recurrence. Because of this peculiarity, radical treatment is generally preferred than conservative surgery. Resection with free margins is associated with lower risk of recurrence but is not recurrence free; thus, the importance of long and scrupulous follow-up is evident. The aim of this study was to present a patient with recurrent mandibular adamantinoma after box resection with safety margins of 1 cm that has necessitated of a segmental resection with 1-step reconstruction with revascularized fibula free flap.

Entities:  

Mesh:

Year:  2011        PMID: 21586980     DOI: 10.1097/SCS.0b013e318210bc34

Source DB:  PubMed          Journal:  J Craniofac Surg        ISSN: 1049-2275            Impact factor:   1.046


  4 in total

Review 1.  Ameloblastoma: a clinical review and trends in management.

Authors:  Andrew C McClary; Robert B West; Ashley C McClary; Jonathan R Pollack; Nancy J Fischbein; Christopher F Holsinger; John Sunwoo; A Dimitrios Colevas; Davud Sirjani
Journal:  Eur Arch Otorhinolaryngol       Date:  2015-04-30       Impact factor: 2.503

2.  A standardized formula for aesthetic mandibular reconstruction using an osteocutaneous fibular free flap.

Authors:  Soung Min Kim; Emmanuel K Amponsah; Hui Young Kim; Ik Jae Kwon; Hoon Myoung; Jong Ho Lee
Journal:  Ghana Med J       Date:  2016-09

Review 3.  Achieving adequate margins in ameloblastoma resection: the role for intra-operative specimen imaging. Clinical report and systematic review.

Authors:  Inoka De Silva; Warren M Rozen; Anand Ramakrishnan; Mansoor Mirkazemi; Charles Baillieu; Ronnie Ptasznik; James Leong
Journal:  PLoS One       Date:  2012-10-19       Impact factor: 3.240

4.  Treatment of recurrent mandibular ameloblastoma.

Authors:  Pedro Infante-Cossio; Victoria Prats-Golczer; Luis-Miguel Gonzalez-Perez; Rodolfo Belmonte-Caro; Rafael Martinez-DE-Fuentes; Eusebio Torres-Carranza; Purificacion Gacto-Sanchez; Tomas Gomez-Cia
Journal:  Exp Ther Med       Date:  2013-06-18       Impact factor: 2.447

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.